The new technologies have been developed in North America and Europe by the private sector. Developing countries will have a limited number of options if they wish to take advantage of the fruits of biotechnological research. One option is for the larger, more advanced countries to invest in domestic biotechnology research suited to national circumstances. Another option would be to leapfrog the technological gap by arranging to share new technologies with the corporations that own the rights to these technologies. Montague Yudelman, Klaus Leisinger of the Novartis Foundation for Sustainable Development, and David Pimentel of Cornell University led the discussion.
Proper citation is required.